These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19386543)

  • 1. Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia.
    Bosboom JL; Stoffers D; Stam CJ; Berendse HW; Wolters ECh
    Clin Neurophysiol; 2009 May; 120(5):910-5. PubMed ID: 19386543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting state oscillatory brain dynamics in Parkinson's disease: an MEG study.
    Bosboom JL; Stoffers D; Stam CJ; van Dijk BW; Verbunt J; Berendse HW; Wolters ECh
    Clin Neurophysiol; 2006 Nov; 117(11):2521-31. PubMed ID: 16997626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies.
    Firbank MJ; Burn DJ; McKeith IG; O'Brien JT
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):776-82. PubMed ID: 16035122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study.
    Olde Dubbelink KT; Stoffers D; Deijen JB; Twisk JW; Stam CJ; Berendse HW
    Neurobiol Aging; 2013 Feb; 34(2):408-18. PubMed ID: 22495052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson's disease: an MEG study.
    Stoffers D; Bosboom JL; Wolters ECh; Stam CJ; Berendse HW
    Exp Neurol; 2008 Sep; 213(1):191-5. PubMed ID: 18590728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D; Mosimann UP; McKeith IG
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):164-71. PubMed ID: 15312280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative electroencephalogram analysis in dementia with Lewy bodies and Alzheimer's disease.
    Kai T; Asai Y; Sakuma K; Koeda T; Nakashima K
    J Neurol Sci; 2005 Oct; 237(1-2):89-95. PubMed ID: 16019033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEG and TMS combined with EEG for mapping alcohol effects.
    Kähkönen S
    Alcohol; 2005 Nov; 37(3):129-33. PubMed ID: 16713500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine in Parkinson's disease dementia.
    Lalli S; Albanese A
    Expert Rev Neurother; 2008 Aug; 8(8):1181-8. PubMed ID: 18671661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical oscillatory power changes during auditory oddball task revealed by spatially filtered magnetoencephalography.
    Ishii R; Canuet L; Herdman A; Gunji A; Iwase M; Takahashi H; Nakahachi T; Hirata M; Robinson SE; Pantev C; Takeda M
    Clin Neurophysiol; 2009 Mar; 120(3):497-504. PubMed ID: 19138878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-frequency MEG activity and MRI evaluation in Parkinson's disease.
    Kotini A; Anninos P; Adamopoulos A; Prassopoulos P
    Brain Topogr; 2005; 18(1):59-63. PubMed ID: 16193267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Background intracranial EEG spectral changes with anti-epileptic drug taper.
    Zaveri HP; Pincus SM; Goncharova II; Novotny EJ; Duckrow RB; Spencer DD; Blumenfeld H; Spencer SS
    Clin Neurophysiol; 2010 Mar; 121(3):311-7. PubMed ID: 20075002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical rhythms reactivity in AD, LBD and normal subjects: a quantitative MEG study.
    Franciotti R; Iacono D; Della Penna S; Pizzella V; Torquati K; Onofrj M; Romani GL
    Neurobiol Aging; 2006 Aug; 27(8):1100-9. PubMed ID: 16076512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovascular coupling in Parkinson's disease patients: effects of dementia and acetylcholinesterase inhibitor treatment.
    Rosengarten B; Dannhardt V; Burr O; Pöhler M; Rosengarten S; Oechsner M; Reuter I
    J Alzheimers Dis; 2010; 22(2):415-21. PubMed ID: 20847429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
    Ballard C; Lane R; Barone P; Ferrara R; Tekin S
    Int J Clin Pract; 2006 Jun; 60(6):639-45. PubMed ID: 16805745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEG resting state functional connectivity in Parkinson's disease related dementia.
    Bosboom JL; Stoffers D; Wolters ECh; Stam CJ; Berendse HW
    J Neural Transm (Vienna); 2009 Feb; 116(2):193-202. PubMed ID: 18982241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming.
    Ponsen MM; Stam CJ; Bosboom JL; Berendse HW; Hillebrand A
    Neuroimage Clin; 2012; 2():95-102. PubMed ID: 24179762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.